Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy STERIS stock

Own STERIS stock in just a few minutes.

STERIS plc is a medical instruments & supplies business based in the US. STERIS shares (STE) are listed on the NYSE and all prices are listed in US Dollars. STERIS employs 13,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in STERIS

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – STE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

STERIS share price

Use our graph to track the performance of STE stocks over time.

STERIS shares at a glance

Information last updated 2021-03-10.
52-week range$104.72 - $203.44
50-day moving average $182.26
200-day moving average $181.65
Wall St. target price$222.00
PE ratio 35.6964
Dividend yield $1.54 (0.86%)
Earnings per share (TTM) $5.03

Buy STERIS shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy STERIS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is STERIS under- or over-valued?

Valuing STERIS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STERIS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STERIS's P/E ratio

STERIS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, STERIS shares trade at around 36x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

STERIS's PEG ratio

STERIS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0587. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into STERIS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

STERIS's EBITDA

STERIS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $810.9 million.

The EBITDA is a measure of a STERIS's overall financial performance and is widely used to measure a its profitability.

STERIS financials

Revenue TTM $3.1 billion
Operating margin TTM 19.62%
Gross profit TTM $1.3 billion
Return on assets TTM 6.29%
Return on equity TTM 11.88%
Profit margin 14.13%
Book value $45.31
Market capitalisation $15.3 billion

TTM: trailing 12 months

Shorting STERIS shares

There are currently 1.6 million STERIS shares held short by investors – that's known as STERIS's "short interest". This figure is 28.2% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting STERIS shares can be evaluated.

STERIS's "short interest ratio" (SIR)

STERIS's "short interest ratio" (SIR) is the quantity of STERIS shares currently shorted divided by the average quantity of STERIS shares traded daily (recently around 659307.59493671). STERIS's SIR currently stands at 2.37. In other words for every 100,000 STERIS shares traded daily on the market, roughly 2370 shares are currently held short.

However STERIS's short interest can also be evaluated against the total number of STERIS shares, or, against the total number of tradable STERIS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case STERIS's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 STERIS shares in existence, roughly 20 shares are currently held short) or 0.0207% of the tradable shares (for every 100,000 tradable STERIS shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against STERIS.

Find out more about how you can short STERIS stock.

STERIS share dividends

25%

Dividend payout ratio: 25.49% of net profits

Recently STERIS has paid out, on average, around 25.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), STERIS shareholders could enjoy a 0.89% return on their shares, in the form of dividend payments. In STERIS's case, that would currently equate to about $1.54 per share.

While STERIS's payout ratio might seem fairly standard, it's worth remembering that STERIS may be investing much of the rest of its net profits in future growth.

STERIS's most recent dividend payout was on 24 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 February 2021 (the "ex-dividend date").

Have STERIS's shares ever split?

STERIS's shares were split on a 2:1 basis on 24 August 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your STERIS shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for STERIS shares which in turn could have impacted STERIS's share price.

STERIS share price volatility

Over the last 12 months, STERIS's shares have ranged in value from as little as $104.7185 up to $203.4406. A popular way to gauge a stock's volatility is its "beta".

STE.US volatility(beta: 0.54)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while STERIS's is 0.5352. This would suggest that STERIS's shares are less volatile than average (for this exchange).

STERIS overview

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site